Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA). - Wikidata - awgldk - TriplyDB

Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).

Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).

http://www.wikidata.org/entity/Q37433075

about

SGLT1 activity in lung alveolar cells of diabetic rats modulates airway surface liquid glucose concentration and bacterial proliferation.

P2860

Q36605834-5535623B-BD37-4212-849B-73851EA59422

P2860

Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).

http://www.wikidata.org/entity/Q37433075

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@en

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@nl

type

label

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@en

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@nl

prefLabel

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@en

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@nl

P1433

Q37433075-AD90C525-4A65-412B-AEFF-A7C403A43D88

P1476

Q37433075-19D305D5-E53D-493D-A3EF-FFAC8A61E61A

P2093

Q37433075-24F93C71-4359-4191-AAC0-866BCBEF700D

Q37433075-3A9C8FF8-A8F0-4024-B59D-33CF6ADA6732

Q37433075-3C2883AB-CD7C-4C93-8843-01B59945FA42

Q37433075-804ACE10-C647-4FD9-A1C3-6B9BA8FA06AB

Q37433075-B4C42B7F-08A2-482A-8C09-F9C4747D9094

Q37433075-C7334577-4A1D-4E21-8B86-0315E11E5FF0

P2860

Q37433075-071BB323-B19A-4156-8DD5-87FBE9D64CC8

Q37433075-1805B10E-548A-4653-8176-1C9A65CFDF58

Q37433075-30838235-3A37-49EC-BF6F-CD8718673272

Q37433075-321C4E7D-0DC5-41CA-BFBB-3B7E65C63034

Q37433075-3351B6EA-A4AB-481A-BB7E-D1C5E4E75D39

Q37433075-398C5A3C-17FE-493A-834D-B968EC12C7F1

Q37433075-3DDA9C1C-3049-4671-B6F8-A35E285A9D06

Q37433075-45022930-E242-4C6A-A0F4-0AD6C469992A

Q37433075-50EE333A-C966-4EDC-AAC8-90826C2C9E23

Q37433075-5D15553C-DCB5-4A57-BD34-74CA22E5C6A6

P304

Q37433075-47BB8789-32CA-41BC-A957-E82ABD0D4DEC

P31

Q37433075-25B88427-5855-4CC0-BCA8-86C652333EDB

P356

Q37433075-40F4B0A6-D4B6-4CBF-AA54-75169E3B37C0

P433

Q37433075-6382E7D3-3C53-4A91-A7B1-9E6789C50693

P478

Q37433075-6898A858-D38D-4D05-9165-ACE861B10BE9

P577

Q37433075-E9432CE1-5758-40F6-8D02-BB1BA014BD45

P5875

Q37433075-D16AB447-DEE5-4C10-BD6F-8C2A67C8CB34

P698

Q37433075-588C23BB-53CC-47D0-B143-E789F4DD7388

P921

Q37433075-57DDF220-07FE-44DA-AF9F-256E98EC14F5

P932

Q37433075-CBF86C5B-2B62-47F4-BDED-C271D315D3F4

P356

P1433

Disease Markers

P1476

Effective assessment of diabet ...... stria; LINUS, Agamatrix, USA).

@en

P2093

B Doubravova

http://www.w3.org/2001/XMLSchema#string

J Bartek

http://www.w3.org/2001/XMLSchema#string

J Zapletalova

http://www.w3.org/2001/XMLSchema#string

O Krystynik

http://www.w3.org/2001/XMLSchema#string

R Chlup

http://www.w3.org/2001/XMLSchema#string

V Prochazka

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous glucose monitoring: evidence and consensus statement for clinical use

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor.

Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Ambulatory glucose profile: representation of verified self-monitored blood glucose data.

A comparative effectiveness analysis of three continuous glucose monitors.

P304

895-905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/702427

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259743936

http://www.w3.org/2001/XMLSchema#string

P698

24427777

http://www.w3.org/2001/XMLSchema#string

P921

P932

3880709

http://www.w3.org/2001/XMLSchema#string